Literature DB >> 27037247

Soluble CD163: A Novel Biomarker with Diagnostic and Therapeutic Implications in Autoimmune Diseases.

Dexi Zhou1, Yaqin Wang1, L U Chen1, Wen Zhang1, Jiajie Luan2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27037247     DOI： 10.3899/jrheum.151317

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  4 in total

1.  Soluble CD163 as a biomarker of periodontal disease - A biochemical study using enzyme-linked immunosorbent assay.

Authors:  Karthikeyan S S Sai; R G Shiva Manjunath; Geetika Kumar; Bharti Chaudhary
Journal:  J Indian Soc Periodontol       Date:  2020-09-01

2.  Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages.

Authors:  Ting Zhang; Hao Li; Kamala Vanarsa; Gabriel Gidley; Chi Chiu Mok; Michelle Petri; Ramesh Saxena; Chandra Mohan
Journal:  Front Immunol       Date:  2020-04-15       Impact factor: 7.561

3.  Urine Soluble CD163 Is a Promising Biomarker for the Diagnosis and Evaluation of Lupus Nephritis.

Authors:  Yun-Ju Huang; Chiung-Hung Lin; Huang-Yu Yang; Shue-Fen Luo; Chang-Fu Kuo
Journal:  Front Immunol       Date:  2022-07-14       Impact factor: 8.786

4.  The Salivary Microbiota of Patients With Primary Biliary Cholangitis Is Distinctive and Pathogenic.

Authors:  Longxian Lv; Huiyong Jiang; Xiaoxiao Chen; Qiangqiang Wang; Kaicen Wang; Jianzhong Ye; Yating Li; Daiqiong Fang; Yingfeng Lu; Liya Yang; Silan Gu; Jianing Chen; Hongyan Diao; Ren Yan; Lanjuan Li
Journal:  Front Immunol       Date:  2021-07-21       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.